1. Quitkin FM, Kane JM, Rifkin A, Ramos-Lorenzi JR, Saraf K, Howard A, et al. Lithium and imipramine in the prophylaxis of unipolar and bipolar II depression: a prospective, placebo-controlled comparison [proceedings]. Psychopharmacol Bull. 1981. 17:142–144.
2. Wehr TA, Goodwin FK. Rapid cycling in manic-depressives induced by tricyclic antidepressants. Arch Gen Psychiatry. 1979. 36:555–559.
Article
3. APA. Diagnostic and Statistical MAnual of Mental disordersm. 1994. 4th edition. Washington, DC: American Psychiatric Association.
4. Leyton F, Barrera A. [Bipolar depression and unipolar depression: differential diagnosis in clinical practice]. Rev Med Chil. 2010. 138:773–779.
5. Akiskal HS, Benazzi F. Continuous distribution of atypical depressive symptoms between major depressive and bipolar II disorders: dose-response relationship with bipolar family history. Psychopathology. 2008. 41:39–42.
Article
6. Van Valkenburg C, Akiskal HS, Puzantian V. Depression spectrum disease or character spectrum disorder? A clinical study of major depressives with familial alcoholism or sociopathy. Compr Psychiatry. 1983. 24:589–595.
7. Coryell W, Endicott J, Maser JD, Keller MB, Leon AC, Akiskal HS. Long-term stability of polarity distinctions in the affective disorders. Am J Psychiatry. 1995. 152:385–390.
Article
8. Goldberg JF, Harrow M, Whiteside JE. Risk for bipolar illness in patients initially hospitalized for unipolar depression. Am J Psychiatry. 2001. 158:1265–1270.
Article
9. Cassano GB, Rucci P, Frank E, Fagiolini A, Dell'Osso L, Shear MK, et al. The mood spectrum in unipolar and bipolar disorder: arguments for a unitary approach. Am J Psychiatry. 2004. 161:1264–1269.
Article
10. Akiskal HS, Benazzi F. The DSM-IV and ICD-10 categories of recurrent [major] depressive and bipolar II disorders: evidence that they lie on a dimensional spectrum. J Affect Disord. 2006. 92:45–54.
Article
11. Akiskal HS, Walker P, Puzantian VR, King D, Rosenthal TL, Dranon M. Bipolar outcome in the course of depressive illness. Phenomenologic, familial, and pharmacologic predictors. J Affect Disord. 1983. 5:115–128.
12. Meyer GJ, Archer RP. The hard science of Rorschach research: what do we know and where do we go. Psychol Assess. 2001. 13:486–502.
Article
13. Ilonen T, Heinimaa M, Korkeila J, Svirskis T, Salokangas RK. Differentiating adolescents at clinical high risk for psychosis from psychotic and non-psychotic patients with the Rorschach. Psychiatry Res. 2010. 179:151–156.
Article
14. Minassian A, Granholm E, Verney S, Perry W. Visual scanning deficits in schizophrenia and their relationship to executive functioning impairment. Schizophr Res. 2005. 74:69–79.
Article
15. Exner J. The Rorschach: A comprehensive system. 1993. New york: Wiley.
16. Singer HK, Brabender V. The use of the Rorschach to differentiate unipolar and bipolar disorders. J Pers Assess. 1993. 60:333–345.
Article
17. Osher Y, Bersudsky Y. Thought disorder in euthymic bipolar patients: a possible endophenotype of bipolar affective disorder? J Nerv Ment Dis. 2007. 195:857–860.
18. Mandel B, Last U, Belmaker RH, Rosenbaum M. Rorschach markers in euthymic manic-depressive illness. Neuropsychobiology. 1984. 12:96–100.
Article
19. Osher Y, Mandel B, Shapiro E, Belmaker RH. Rorschach markers in offspring of manic-depressive patients. J Affect Disord. 2000. 59:231–236.
Article
20. Decina P, Kestenbaum CJ, Farber S, Kron L, Gargan M, Sackeim HA, et al. Clinical and psychological assessment of children of bipolar probands. Am J Psychiatry. 1983. 140:548–553.
Article
21. Nierenberg AA, Akiskal HS, Angst J, Hirschfeld RM, Merikangas KR, Petukhova M, et al. Bipolar disorder with frequent mood episodes in the national comorbidity survey replication (NCS-R). Mol Psychiatry. 2010. 15:1075–1087.
Article
22. Pani PP, Maremmani I, Trogu E, Gessa GL, Ruiz P, Akiskal HS. Delineating the psychic structure of substance abuse and addictions: should anxiety, mood and impulse-control dysregulation be included? J Affect Disord. 2010. 122:185–197.
Article
23. Swann AC, Steinberg JL, Lijffijt M, Moeller GF. Continuum of depressive and manic mixed states in patients with bipolar disorder: quantitative measurement and clinical features. World Psychiatry. 2009. 8:166–172.
Article
24. Thase ME. Bipolar depression: Issues in Diagnosis and Treatment. Harv Rev Psychiatry. 2005. 13:257–271.
Article
25. Correll CU, Penzner JB, Frederickson AM, Richter JJ, Auther AM, Smith CW, et al. Differentiation in the preonset phases of schizophrenia and mood disorders: evidence in support of a bipolar mania prodrome. Schizophr Bull. 2007. 33:703–714.
Article
26. Bora E, Vahip S, Akdeniz F, Ilerisoy H, Aldemir E, Alkan M. Executive and verbal working memory dysfunction in first-degree relatives of patients with bipolar disorder. Psychiatry Res. 2008. 161:318–324.
Article
27. Shin KJ, Won HT. Rorschach Responses in Korean Normal Adults. Korean J Clin Psychol. 1991. 10:206–216.
28. Yoo IO, Park SW, Joo YH. The Comparative Study of Manic Group and Schizophrenic Group on Rorschach Responses. Korean J Clin Psychol. 1993. 12:62–72.
29. Ogdon DP. Handbook of psychological signs, symptoms, and syndromes. 1981. California: Western psychological services.
30. Benazzi F. Bipolar II depression in late life: prevalence and clinical features in 525 depressed outpatients. J Affect Disord. 2001. 66:13–18.
Article